The authors demonstrated that the oncolytic virus, Coxsackievirus A21, could kill a range of B cell neoplasms, irrespective of an anti-viral interferon response.
[Molecular Therapy Oncolytics]
Efficacy of Coxsackievirus A21 against Drug-Resistant Neoplastic B Cells
